Highlights
- Market Cap
- $7.85M
- Enterprise Value
- $31.34M
- EPS (TTM)
- $0.57
- PE Ratio
- 17.68
- Total Revenue (TTM)
- $71.00K
- Gross Profit (TTM)
- -$207.00K
- EBITDA (TTM)
- -$6.39M
- Year Range
- $6.00 - $28.44
- ROA (TTM)
- 1.03%
- ROE (TTM)
- 1.18%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in PAVmed Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
PAVmed Inc. (PAVM) has returned 53.23% so far this year and -53.10% over the past 12 months.
PAVmed Inc.
- 1D
- 3.57%
- 1M
- 0.69%
- YTD
- 53.23%
- 6M
- -21.50%
- 1Y
- -53.10%
- 3Y*
- -60.77%
- 5Y*
- -66.01%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Jul 28, 2016, PAVM's average daily return is -0.08%, while the average monthly return is -2.99%.
Historically, 35% of months were positive and 65% were negative. The best month was Feb 2021 with a return of +104.9%, while the worst month was Jun 2024 at -43.8%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 9 months.
On a daily basis, PAVM closed higher 44% of trading days. The best single day was Jan 21, 2026 with a return of +94.7%, while the worst single day was Aug 17, 2022 at -30.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 17.00% | 30.06% | 0.69% | 53.23% | |||||||||
| 2025 | 5.82% | 11.45% | -2.51% | 0.44% | -17.09% | -0.08% | -4.10% | -15.74% | -11.15% | -0.49% | -13.99% | -40.15% | -64.81% |
| 2024 | -43.69% | 14.22% | -19.25% | -6.54% | -27.50% | -43.79% | 6.13% | 5.21% | 35.16% | -13.01% | -9.35% | -35.31% | -84.77% |
| 2023 | 6.52% | -9.45% | -19.33% | 17.80% | -8.84% | 1.67% | -7.90% | -16.59% | -5.97% | -11.30% | 18.25% | -11.11% | -42.78% |
| 2022 | -30.08% | -11.05% | -13.73% | -3.79% | -20.47% | -7.46% | 29.45% | -1.65% | -27.73% | 44.19% | -43.55% | -31.43% | -80.49% |
| 2021 | -3.30% | 104.88% | 5.71% | 2.93% | 15.97% | 20.75% | 7.34% | 6.26% | 16.99% | -36.42% | -32.41% | -32.97% | 16.04% |
Benchmark Metrics
PAVmed Inc. has an annualized alpha of -27.19%, beta of 0.93, and R² of 0.03 versus S&P 500 Index. Calculated based on daily prices since July 29, 2016.
- This stock participated in 170.56% of S&P 500 Index downside but only -76.52% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.03 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -27.19%
- Beta
- 0.93
- R²
- 0.03
- Upside Capture
- -76.52%
- Downside Capture
- 170.56%
Return for Risk
Risk / Return Rank
PAVM ranks 21 for risk / return — below 21% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for PAVmed Inc. (PAVM) and compare them to a chosen benchmark (S&P 500 Index).
| PAVM | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.41 | 0.90 | -1.31 |
Sortino ratioReturn per unit of downside risk | -0.13 | 1.39 | -1.52 |
Omega ratioGain probability vs. loss probability | 0.98 | 1.21 | -0.23 |
Calmar ratioReturn relative to maximum drawdown | -0.73 | 1.40 | -2.13 |
Martin ratioReturn relative to average drawdown | -1.18 | 6.61 | -7.78 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore PAVM risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the PAVmed Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the PAVmed Inc. was 99.91%, occurring on Jan 20, 2026. The portfolio has not yet recovered.
The current PAVmed Inc. drawdown is 99.85%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.91% | Aug 5, 2016 | 2377 | Jan 20, 2026 | — | — | — |
| -13.33% | Aug 3, 2016 | 1 | Aug 3, 2016 | 1 | Aug 4, 2016 | 2 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of PAVmed Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how PAVmed Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for PAVM, comparing it with other companies in the Medical Devices industry. Currently, PAVM has a P/E ratio of 17.7. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PAVM relative to other companies in the Medical Devices industry. Currently, PAVM has a P/S ratio of 99.8. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PAVM in comparison with other companies in the Medical Devices industry. Currently, PAVM has a P/B value of 0.8. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |